Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma
Molecules · 28.01.2023 · 28 (3) · 1238
DOI: 10.3390/molecules28031238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 28.01.2023. Verfasst von Qiong-Ying Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou 318000, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Prostatic Neoplasms, Nuclear Receptor Subfamily 4, Group A, Member 1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Experiment Animal Science and Technology Project of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Prostate adenocarcinoma (PRAD) is the most frequent malignancy, and is the second leading cause of death due to cancer in men. Thus, new prognostic biomarkers and drug targets for PRAD are urgently needed. As we know, nuclear receptor Nur77 is important in cancer development and changes in the tumor microenvironment; whereas, the function of Nur77 in PRAD remains to be elucidated. The TCGA database was used to explore the Nur77 expression and its role in the prognosis of PRAD. It was shown that Nur77 was down regulated in PRAD, and low Nur77 expression was correlated with advanced clinical pathologic characteristics (high grade, histological type, age) and poor prognosis. Furthermore, key genes screening was examined by univariate Cox analysis and Kaplan-Meier survival. Additionally, Nur77 was closely related to immune infiltration and some anti-tumor immune functions. The differentially expressed genes (DEGs) were presented by protein-protein interaction (PPI) network analysis. Therefore, the expression level of Nur77 might help predict the survival of PRAD cases, which presents a new insight and a new target for the treatment of PRAD. In vitro experiments verified that natural product malayoside targeting Nur77 exhibited significant therapeutic effects on PRAD and largely induced cell apoptosis by up-regulating the expression of Nur77 and its mitochondrial localization. Taken together, Nur77 is a prognostic biomarker for patients with PRAD, which may refresh the profound understanding of PRAD individualized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou 318000, China.
- Department of Pharmacy, Hebei Key Laboratory of Neuropharmacology, Hebei North University, Zhangjiakou 075000, China.
- School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
- School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230038, China.
- Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Jing-Hui Wang
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Experiment Animal Science and Technology Project of Zhejiang Province
- National Natural Science Foundation of China
- The Outstanding Youth Program of the Anhui Provincial Department of Education
- Natural Science Foundation of Fujian Province of China
Zitieren
APA
Hu, Q. Y., Liu, J., Zhang, X. K., Yang, W. T., Tao, Y. T., Chen, C., Qian, Y. H., Tang, J. S., Yao, X. S., Xu, Y. H., & Wang, J. H. (2023). Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma. Molecules, 28(3), 1238. https://doi.org/10.3390/molecules28031238
Vancouver
Hu QY, Liu J, Zhang XK, Yang WT, Tao YT, Chen C, et al. Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma. Molecules. 2023;28(3):1238. doi:10.3390/molecules28031238
BibTeX
@article{Hu2023,
author = {Hu, Qiong-Ying and Liu, Jie and Zhang, Xiao-Kun and Yang, Wan-Ting and Tao, Yu-Tian and Chen, Ce and Qian, Ye-He and Tang, Jin-Shan and Yao, Xin-Sheng and Xu, Ying-He and Wang, Jing-Hui},
title = {Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma},
journal = {Molecules},
year = {2023},
volume = {28},
number = {3},
pages = {1238},
doi = {10.3390/molecules28031238}
}
EUVIMED